ZIVO
Zivo Bioscience Inc
CEO
Andrew Dahl
Employees
2
Industry
Biological Product (except Diagnostic) Manufacturing
zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.
Loading...
Open
19.25
Mkt cap
68M
Volume
200
High
19.25
P/E Ratio
-3.99
52-wk high
22.15
Low
19.25
Div yield
N/A
52-wk low
1.20

Portfolio Pulse from Benzinga Newsdesk
June 04, 2024 | 3:28 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.